BenQ Medical Technology (ROCO:4116) Research & Development: NT$35 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4116 BenQ Medical Technology Corp ROCO:4116
81 GF Score
Price NT$38.60
GF Value NT$62.38
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is BenQ Medical Technology Research & Development?

BenQ Medical Technology ROCO:4116 +0.39% 81 Research & Development is NT$35 Mil as of Dec. 2025. GuruFocus rates ROCO:4116 with a GF Score™ of 81/100 and a GF Value™ of NT$62.38 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BenQ Medical Technology's Research & Development for the three months ended in Dec. 2025 was NT$9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$35 Mil.

BenQ Medical Technology  (ROCO:4116) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BenQ Medical Technology Research & Development Related Terms

BenQ Medical Technology Research & Development Historical Data

* Premium members only.

The historical data trend for BenQ Medical Technology's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BenQ Medical Technology Research & Development Chart

BenQ Medical Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.65 39.58 31.96 36.39 34.69

BenQ Medical Technology Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.32 8.26 9.20 8.44 8.79
ROCO:4116
81GF Score
BenQ Medical Technology Corp ROCO:4116
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BenQ Medical Technology Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$35 Mil mean?
BenQ Medical Technology (ROCO:4116) has a Research & Development of NT$35 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on BenQ Medical Technology and its competitors.
Is BenQ Medical Technology's Research & Development too high?
BenQ Medical Technology's current Research & Development is NT$35 Mil. Overall, BenQ Medical Technology has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's Research & Development compare to ISRG and BDX?
BenQ Medical Technology's Research & Development of NT$35 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BenQ Medical Technology and its competitors. BenQ Medical Technology's current Research & Development is NT$35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$62.38, compared to a current price of NT$38.60 — trading 38.1% below its estimated fair value. The current Research & Development is NT$35 Mil. BenQ Medical Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current Research & Development is NT$35 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?

Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued. The current stock price of NT$38.60 is trading 38.1% below its estimated GF Value™ of NT$62.38. GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.

Key valuation signals for ROCO:4116:

  • Research & Development: NT$35 Mil
  • GF Value™: NT$62.38 vs. price of NT$38.60 (38.1% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BenQ Medical Technology Business Description

Address No.46, Zhouzi Street, 7th Floor, Neihu District, Taipei, TWN, 11493
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score

Get the complete analysis for ROCO:4116

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.60
Price
NT$62.38
GF Value